Learn More
Bachem C-Peptide (human) Trifluoroacetate

Supplier: Bachem 4009494.0500
C-Peptide (human) Trifluoroacetate, H-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH, 33017-11-7, C129H211N35O48, Mr 3020.30, 0.5mg. Insulin Precursor (57-87) (human). The measurement of the C-peptide under standardized conditions provides a sensitive, well accepted, and clinically validated assessment of b-cell function. The C-peptide measurement is the most suitable primary outcome for clinical trials of therapies aimed at preserving or improving endogenous insulin secretion in type 1 diabetes patients. C-peptide also shows hormonal activity. Clinical studies demonstrated that C-peptide administration in type 1 diabetes patients, who lack the peptide, alleviates the diabetes-induced renal and nerve dysfunctions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.